DQB1*06: 02-associated pathogenic anti-myelin autoimmunity in multiple sclerosis-like disease: Potential function of DQB1*06:02 as a disease-predisposing allele

Frontiers in Oncology

Volumn 4, Issue OCT, 2014, Pages

  Kaushansky, Nathali ^a   Ben Nun, Avraham ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Antigens peptides epitopes; HLA DR15 Tg mice; MS EAE; Neuroimmunology; T cells

Indexed keywords

HLA DQB1 ANTIGEN; MYELIN;

AUTOIMMUNITY; DISEASE PREDISPOSITION; EPISTASIS; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IMMUNOMODULATION; IN SITU HYBRIDIZATION; MULTIPLE SCLEROSIS; NONHUMAN; NORTHERN BLOTTING; REVIEW;

EID: 84987962229     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00280     Document Type: Review

References (51)

1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol (2005) 23:683-747. doi: 10.1146/annurev.immunol.23.021704.115707
2. Compston DA, Batchelor JR, McDonald WI. B-lymphocyte alloantigens associated with multiple sclerosis. Lancet (1976) 2(7998):1261-5. doi:10.1016/S0140-6736(76)92027-4
3. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens (1991) 38(1):1-15. doi:10.1111/j.1399-0039.1991.tb02029.x
4. International Multiple Sclerosis Genetics C, Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 45(11):1353-60. doi:10.1038/ng.2770
5. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron (2006) 52(1):61-76. doi:10.1016/j.neuron.2006.09.011
6. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet (2006) 15(18):2813-24. doi:10.1093/hmg/ddl223
7. Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, Noble JA, et al. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet (2013) 9(11):e1003926. doi:10.1371/journal.pgen.1003926
8. Altmann DM, Douek DC, Frater AJ, Hetherington CM, Inoko H, Elliott JI. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med (1995) 181(3):867-75. doi:10.1084/jem.181.3.867
9. Rich C, Link JM, Zamora A, Jacobsen H, Meza-Romero R, Offner H, et al. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice. Eur J Immunol (2004) 34(5):1251-61. doi:10.1002/eji.200324354
10. Kaushansky N, Altmann DM, Ascough S, David CS, Lassmann H, Ben-Nun A. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. J Immunol (2009) 183(5):3531-41. doi:10.4049/jimmunol.0900784
11. Kaushansky N, Altmann DM, David CS, Lassmann H, Ben-Nun A. DQB1*602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP). J Neuroinflammation (2012) 9:29-43. doi:10.1186/1742-2094-9-29
12. Serjeantson SW, Gao X, Hawkins BR, Higgins DA, Yu YL. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur J Immunogenet (1992) 19(1-2):11-9. doi:10.1111/j.1744-313X.1992.tb00043.x
13. Alves-Leon SV, Papais-Alvarenga R, Magalhaes M, Alvarenga M, Thuler LC. Fernandez y Fernandez O: ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol Scand (2007) 115(5):306-11. doi:10.1111/j.1600-0404.2006.00750.x
14. Fernandez O, Fernandez V, Alonso A, Caballero A, Luque G, Bravo M, et al. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain. J Neurol (2004) 251(4):440-4. doi:10.1007/s00415-004-0350-2
15. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet (2008) 9(7):516-26. doi:10.1038/nrg2395
16. McElroy JP, Oksenberg JR. Multiple sclerosis genetics. Neurol Clin (2010) 29(2):219-31. doi:10.1016/j.ncl.2010.12.002
17. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 476(7359):214-9. doi:10.1038/nature10251
18. Oksenberg JR, Baranzini SE. Multiple sclerosis genetics-is the glass half full, or half empty? Nat Rev Neurol (2010) 6(8):429-37. doi:10.1038/nrneurol.2010.91
19. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet (2004) 74(1):160-7. doi:10.1086/380997
20. Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci U S A (2009) 106(18):7542-7. doi:10.1073/pnas.0812664106
21. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol (2000) 48(2):211-9. doi:10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO;2-R
22. Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, DeLuca GC, Lincoln MR, et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet (2007) 3(9):1607-13. doi:10.1371/journal.pgen.0030150
23. Spurkland A, Celius EG, Knutsen I, Beiske A, Thorsby E, Vartdal F. The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer. Tissue Antigens (1997) 50(1):15-22. doi:10.1111/j.1399-0039.1997.tb02828.x
24. Sakai K, Sinha AA, Mitchell DJ, Zamvil SS, Rothbard JB, McDevitt HO, et al. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc Natl Acad Sci U S A (1988) 85(22):8608-12. doi:10.1073/pnas.85.22.8608
25. Whitham RH, Jones RE, Hashim GA, Hoy CM, Wang RY, Vandenbark AA, et al. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice. J Immunol (1991) 147(11):3803-8.
26. Kerlero de Rosbo N, Mendel I, Ben-Nun A. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur J Immunol (1995) 25(4):985-93. doi:10.1002/eji.1830250419
27. Mendel Kerlero de Rosbo N, Ben-Nun A. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. Eur J Immunol (1996) 26(10):2470-9.
28. Johns TG, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales MF, Bernard CC. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol (1995) 154(10):5536-41.
29. Kerlero de Rosbo N, Brok HP, Bauer J, Kaye JF, Hart BA, Ben-Nun A. Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterisation of immunodominant T-and B-cell epitopes. J Neuroimmunol (2000) 110(1-2):83-96. doi:10.1016/S0165-5728(00)00306-4
30. Kaye JF, Kerlero de Rosbo N, Mendel I, Flechter S, Hoffman M, Yust I, et al. The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS). J Neuroimmunol (2000) 102(2):189-98. doi:10.1016/S0165-5728(99)00168-X
31. Madsen LS, Andersson EC, Jansson L, Krogsgaard M, Andersen CB, Engberg J, et al. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 23(3):343-7. doi:10.1038/15525
32. Sireci G, Dieli F, Caccamo N, Barera A, Carta P, Di Sano C, et al. A human leucocyte antigen-DR1 transgene confers susceptibility to experimental allergic encephalomyelitis elicited by an epitope of myelin basic protein. Scand J Immunol (2003) 58(2):188-94. doi:10.1046/j.1365-3083.2003.01296.x
33. Das P, Drescher KM, Geluk A, Bradley DS, Rodriguez M, David CS. Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. Hum Immunol (2000) 61(3):279-89. doi:10.1016/S0198-8859(99)00135-4
34. Ito K, Bian HJ, Molina M, Han J, Magram J, Saar E, et al. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med (1996) 183(6):2635-44. doi:10.1084/jem.183.6.2635
35. Kawamura K, Yamamura T, Yokoyama K, Chui DH, Fukui Y, Sasazuki T, et al. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice. J Clin Invest (2000) 105(7):977-84. doi:10.1172/JCI8407
36. Friese MA, Jakobsen KB, Friis L, Etzensperger R, Craner MJ, McMahon RM, et al. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med (2008) 14(11):1227-35. doi:10.1038/nm.1881
37. Forsthuber TG, Shive CL, Wienhold W, de Graaf K, Spack EG, Sublett R, et al. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J Immunol (2001) 167(12):7119-25. doi:10.4049/jimmunol.167.12.7119
38. Khare M, Rodriguez M, David CS. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. Int Immunol (2003) 15(4):535-46. doi:10.1093/intimm/dxg053
39. Kerlero de Rosbo N, Hoffman M, Mendel I, Yust I, Kaye J, Bakimer R, et al. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol (1997) 27(11):3059-69. doi:10.1002/eji.1830271144
40. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes (2008) 57(4):1084-92. doi:10.2337/db07-1331
41. Pollinger B, Krishnamoorthy G, Berer K, Lassmann H, Bosl MR, Dunn R, et al. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J Exp Med (2009) 206(6):1303-16. doi:10.1084/jem.20090299
42. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med (2003) 197(9):1073-81. doi:10.1084/jem.20021603
43. Khare M, Mangalam A, Rodriguez M, David CS. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice. J Neuroimmunol (2005) 169(1-2):1-12. doi:10.1016/j.jneuroim.2005.07.023
44. Mangalam A, Luckey D, Basal E, Jackson M, Smart M, Rodriguez M, et al. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice. J Immunol (2009) 182(8):5131-9. doi:10.4049/jimmunol.0803918
45. Yamamoto Y, Mizuno R, Nishimura T, Ogawa Y, Yoshikawa H, Fujimura H, et al. Cloning and expression of myelin-associated oligodendrocytic basic protein. A novel basic protein constituting the central nervous system myelin. J Biol Chem (1994) 269(50):31725-30.
46. Schaeren-Wiemers N, Schaefer C, Valenzuela DM, Yancopoulos GD, Schwab ME. Identification of new oligodendrocyte-and myelin-specific genes by a differential screening approach. J Neurochem (1995) 65(1):10-22. doi:10.1046/j.1471-4159.1995.65010010.x
47. de Rosbo NK, Kaye JF, Eisenstein M, Mendel I, Hoeftberger R, Lassmann H, et al. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J Immunol (2004) 173(2):1426-35. doi:10.4049/jimmunol.173.2.1426
48. Holz A, Bielekova B, Martin R, Oldstone MB. Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis. J Immunol (2000) 164(2):1103-9. doi:10.4049/jimmunol.164.2.1103
49. Greer JM, Csurhes PA, Cameron KD, McCombe PA, Good MF, Pender MP. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. Brain (1997) 120(Pt 8):1447-60. doi:10.1093/brain/120.8.1447
50. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med (2008) 14(3):337-42. doi:10.1038/nm1715
51. Tjon JM, van Bergen J, Koning F. Celiac disease: how complicated can it get? Immunogenetics (2010) 62(10):641-51. doi:10.1007/s00251-010-0465-9